Contact Us

Ortho Evra
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Did you experience any of the following complications during or after using Ortho Evra?

Do you smoke?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Mom Says Ortho Evra Killed Her Daughter

Oct 22, 2009 | Parker Waichman LLP

The Ortho Evra birth control patch is being blamed for the death of a young Boston woman.  According to a report in the Boston Globe, 17-year-old Adrianna Niedner died on September 28 of a pulmonary emboli.  Now her mother is questioning why Ortho Evra has been allowed to remain on the market for so long.

Anyone who is a regular reader of this blog is familiar with the controversy surrounding Ortho Evra. When the contraceptive patch was introduced in 2002, Johnson & Johnson touted it as a convenient alternative to daily oral contraceptive pills, and its original safety label stated that the patch’s health risks were similar to those of oral contraceptives. But in 2005, the Food & Drug Administration (FDA) warned that women using Ortho Evra were exposed to approximately 60 percent more estrogen than those who use oral contraceptive pills. High levels of estrogen can greatly increase the risk of developing blood clots, heart attacks, strokes and other serious injuries. As of November 2005, the FDA had received twenty-one reports of life-threatening blood clots and other ailments associated with the use of Ortho Evra.

In 2006, a study was published that showed women using Ortho Evra were twice as likely to suffer a type of blood clot called venous thromboembolisms (VTEs) — a clot that can travel to the lungs and cause a fatal pulmonary embolism – as those taking oral birth control pills. That study prompted the FDA to request a change on the Ortho Evra label to include a stronger safety warning. In January 2008, the FDA asked that the Ortho Evra label be changed yet again to include information on another study that indicated the patch doubles the risk of developing VTEs compared to the Pill.

Thousands of Ortho Evra users have  filed lawsuits against Johnson & Johnson for injuries, including blood clots, heart attacks and strokes,  they claim were the result of the patch.  At least 20 of the women named in the lawsuits died after using it.  According to the Boston Globe, two whistleblowers have also come forward to say Johnson & Johnson was downplaying its risks. Last October, we reported that the drug maker had spent just over $68 million to settle hundreds of lawsuit.

Adrianna Niedner had just begun her freshman year at Trinity College when she collapsed in her dorm room.  According to the Boston Globe, Leslie Niedner began to suspect that Ortho Evra played a role in her daughter's death when someone asked if Adrianna had used it.  An internet search quickly revealed dozens of similar stories.  Leslie is now convinced that Ortho Evra caused the blood clot that killed her daughter.  

Leslie is among the many who have sued Johnson & Johnson over Ortho Evra, but according to the Boston Globe, she appears unwilling to accept a settlement.  Leslie wants to take Johnson & Johnson to court.

What Leslie most  wants, however,  is to have Ortho  Evra  removed from the market.  Sidney Wolfe, the director of the Health Research Group at the consumer advocacy group, Public Citizen, agrees  with her, and calls the patch "needlessly dangerous."  

Unfortunately, it doesn't look like that will happen anytime soon.  Though sales of Ortho Evra have dropped 75 percent since its dangerous side effects were publicized, at least 2 million women are still using the patch.

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo